Supernus Pharmaceuticals | SUPN - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 10.57B 171M 2025-12
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Canopy Growth CAD 140.42M 113.56M 2025-12
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Eisai JPY 227B 22.05B 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Novo Nordisk DKK 106.26B 11.21B 2026-03
Pacira USD 125.64M 1.57M 2026-03
Perrigo USD 697.1M 84.3M 2026-03
Pfizer USD 16.17B 332M 2026-03
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12